Press Release

United Kingdom Breast Cancer Therapeutics Market to be Dominated by Targeted Therapy through 2028

increasing prevalence of breast cancer and changing lifestyle are expected to drive the United Kingdom Breast Cancer Therapeutics Market in the forecast period, 2024-2028.

 

According to TechSci Research report, “United Kingdom Breast Cancer Therapeutics Market – By Region, Competition Forecast and Opportunities, 2018-2028,” the United Kingdom Breast Cancer Therapeutics Market is projected to experience substantial growth during the forecast period of 2024-2028. The market for breast cancer therapeutics is witnessing significant expansion, driven by the increasing prevalence of breast cancer and growing investments in healthcare research and innovation. Notably, the rising obesity rates in the United Kingdom contribute to an elevated risk of breast cancer, as obesity affects hormone levels, specifically leading to increased estrogen production, which is associated with hormone receptor-positive breast cancer development. Consequently, the mounting prevalence of obesity underscores the urgent requirement for innovative therapeutics tailored to obese patients, considering their distinct physiological characteristics and treatment responses. Moreover, alcohol consumption has been linked to an increased risk of breast cancer and given the significant drinking culture in the United Kingdom, addressing the harmful use of alcohol is crucial in mitigating the burden of breast cancer. Alcohol can disrupt hormone levels, impair DNA repair mechanisms, and promote oxidative stress, all contributing to the development of breast cancer.

Therefore, addressing alcohol-related breast cancer risk necessitates public health initiatives to raise awareness and promote responsible alcohol consumption, as well as the development of targeted therapies. The interplay between age, obesity, alcohol misuse, and family history of breast cancer shapes the landscape of breast cancer therapeutics in the United Kingdom. To improve prevention, diagnosis, and treatment, a comprehensive approach is required, including the development of targeted therapeutics tailored to specific patient profiles based on age, body composition, alcohol consumption patterns, and genetic predisposition. Nonetheless, challenges persist, such as high treatment costs, access disparities, and the ongoing need for research and development. Ensuring equitable access to state-of-the-art treatments and addressing healthcare disparities are crucial aspects that must be tackled to enhance breast cancer outcomes for all patients in the United Kingdom, which may impact the market's growth in the forecast period.


 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on United Kingdom Breast Cancer Therapeutics Market “.


 

The United Kingdom Breast Cancer Therapeutics Market is categorized into Therapy, End User, Region and Competitive Landscape.

Regarding Therapy, the market is segmented into Chemotherapy, Hormone Therapy, Immunotherapy, Targeted Therapy, and Others Chemotherapy are projected to experience growth during the forecast period. These treatments for breast cancer often exhibit fewer side effects as they specifically target the abnormalities in cancer cells, sparing healthy, normal cells. These therapies focus on specific regions within or on the tumor cells. While targeted therapies may not be suitable for all breast cancer patients, which is expected to contribute to market growth in the future.

In terms of End User, the market is divided into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others. The hospitals segment is anticipated to witness growth in the forecast period due to the availability of advanced facilities for both in-patient and out-patient treatments, as well as diagnostic services. Furthermore, the presence of skilled healthcare professionals in hospitals is contributing to the expansion of the United Kingdom Breast Cancer Therapeutics Market.

Major companies operating in the United Kingdom Breast Cancer Therapeutics Market are:

  • Novartis AG
  • Pfizer Inc
  • Eli Lilly & Company
  • Merck Co. & Inc.
  • GlaxoSmithKline, Plc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Sanofi S.A.
  • Mylan NV


Download Free Sample Report

Customers can also request 10% free customization in this report.


“The United Kingdom Breast Cancer Therapeutics Market is poised to experience significant growth in the coming years. This is attributed to the rising prevalence of breast cancer cases in the country, primarily due to the aging population and changing lifestyles of women. The market will be driven by increasing healthcare expenditure and government initiatives focused on research and innovation. Additionally, the adoption of revolutionary technological advancements in the medical therapeutics industry and the expansion of hospitals and healthcare professionals in the nation will further bolster market growth. It is anticipated that the market will continue to grow through 2028,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United Kingdom Breast Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Immunotherapy, Targeted Therapy, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2018-2028F,” has evaluated the future growth potential of United Kingdom Breast Cancer Therapeutics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the United Kingdom Breast Cancer Therapeutics Market.


Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com               

Relevant Reports

United Kingdom Breast Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Immunotherapy, Targeted Therapy, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2018-2028F

Healthcare | Oct, 2023

Increasing prevalence of breast cancer and changing lifestyle are expected to drive the United Kingdom Breast Cancer Therapeutics Market in the forecast period, 2024-2028.

Relevant News